Richardpruen (talk | contribs) (added studies) |
Richardpruen (talk | contribs) (→Studies/papers: added more detail) |
||
| Line 42: | Line 42: | ||
=What are the symptoms of COPD?= | =What are the symptoms of COPD?= | ||
Symptoms include: | Symptoms include: | ||
| Line 51: | Line 50: | ||
You might get these symptoms all the time, or they might appear or get worse when you have an infection or breathe in smoke or fumes. | You might get these symptoms all the time, or they might appear or get worse when you have an infection or breathe in smoke or fumes. | ||
If you have COPD that has a severe impact on your breathing, you can lose your appetite, lose weight and find that your ankles swell. | If you have COPD that has a severe impact on your breathing, you can lose your appetite, lose weight and find that your ankles swell. | ||
== Studies/papers == | == Studies/papers == | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up] | 2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up] | ||
2021: [https://link.springer.com/article/10.1007/s11739-021-02674-3 Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up] | |||
2022: [https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00284-0 Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial] | |||
[ | * A harm reduction approach with the goal of achieving CC switching may be a more pragmatic approach, making EC use particularly appropriate with COPD [25]. EC represent a potentially effective harm reduction tool that is safer than smoking CC [18, 23, 24]. Smokers with COPD, however, tend to be older and may have a higher level of addiction to nicotine than the average smoker and the feasibility and preliminary effectiveness of an EC harm-reduction strategy in a COPD population has not been explored. | ||
* Our study protocol has a few limitations. First, as a pilot study the protocol is not powered to detect small differences in CPD or CAT Scores between the NRT and EC arms. Second, CAT Score is not the gold standard for the assessment of respiratory health. | |||
=External Links= | =External Links= | ||
edits